See Hui-Qi, Chan Jin-Ning, Ling Shu-Jin, Gan Shang-Cheng, Leong Chee-Onn, Mai Chun-Wai
School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, Malaysia.
J Pharm Pharm Sci. 2018;21(1):217-221. doi: 10.18433/jpps29869.
Big data is anticipated to have large implications in clinical pharmacy, in view of its potential in enhancing precision medicine and to avoid medication error. However, it is equally debatable since such a powerful tool may also disrupt the need of pharmacist in healthcare industry. In this article, we commented the contribution of Big Data in various aspects of clinical pharmacy including advancing pharmaceutical care service, optimising drug supplies, managing clinical trials, and strengthening pharmacovigilance. The future direction of the usage of Big Data related to clinical pharmacy will be discussed. This article is open to POST-PUBLICATION REVIEW. Registered readers (see "For Readers") may comment by clicking on ABSTRACT on the issue's contents page.
鉴于大数据在推动精准医疗和避免用药错误方面的潜力,预计其在临床药学中将产生重大影响。然而,这同样存在争议,因为这样一个强大的工具也可能削弱医疗行业对药剂师的需求。在本文中,我们评论了大数据在临床药学各个方面的贡献,包括推进药学服务、优化药品供应、管理临床试验以及加强药物警戒。还将讨论与临床药学相关的大数据使用的未来方向。本文接受发表后评审。注册读者(见“致读者”)可通过点击本期目录页面上的摘要进行评论。